Hebrew
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
creatine/infarction
הקישור נשמר בלוח
10 תוצאות
Inhibition of thrombin-induced platelet aggregation by creatine kinase inhibitors
רק משתמשים רשומים יכולים לתרגם מאמרים
התחבר הרשם
FIELD OF THE INVENTION
The present invention relates to a new method of use for creatine compounds such as creatine kinase inhibitors and, more particularly, cyclocreatine, to block intracellular signals of the thrombin receptor Protease Activated Receptor-1, to thereby inhibit thrombin-induced
Immunochemical assay for creatine kinase-MB isoenzyme
רק משתמשים רשומים יכולים לתרגם מאמרים
התחבר הרשם
BACKGROUND OF THE INVENTION
Creatine kinase (CK) occurs in animal body fluids and tissue in the form of three known isoenzymes, designated CK-BB, CK-MM and CK-MB. Each of these three isoenzymes, namely CK-BB, CK-MM, and CK-MB, differs one from the other by virtue of containing a different
Immunochemical assay for creatine kinase-MB isoenzyme
רק משתמשים רשומים יכולים לתרגם מאמרים
התחבר הרשם
BACKGROUND OF THE INVENTION
Creatine kinase (CK) occurs in animal body fluids and tissue in the form of three known isoenzymes, designated CK-BB, CK-MM and CK-MB. Each of these three isoenzymes, namely CK-BB, CK-MM, and CK-MB, differs one from the other by virtue of containing a different
Method for the determination of creatine phosphokinase enzyme
רק משתמשים רשומים יכולים לתרגם מאמרים
התחבר הרשם
BACKGROUND OF THE INVENTION, AND ITS UTILITY
This invention relates to the detection and quantification of serum enzymes in living organisms. The term, serum enzyme, as used herein is meant to include those enzymes occurring normally in the serum, but whose concentration will depend upon or be
Method for the prevention of apoptosis
רק משתמשים רשומים יכולים לתרגם מאמרים
התחבר הרשם
FIELD OF THE INVENTION
This invention relates to a method for inhibiting apoptosis in ischemic-reperfused myocardium. More specifically this invention relates to a method for using heparin or noncoagulant heparin in the prevention of apoptosis.
BACKGROUND OF THE INVENTION
Cells die by one of either
Methods for evaluating therapies and predicting clinical outcome related to coronary conditions
רק משתמשים רשומים יכולים לתרגם מאמרים
התחבר הרשם
FIELD OF THE INVENTION
The present invention concerns methods of predicting clinical outcomes such as likelihood of mortality or death, new congestive heart failure, new pulmonary congestion or the like in a patient that has received reperfusion therapy such as thrombolytic therapy.
BACKGROUND OF
Application of irisin in myocardial ischemia reperfusion
רק משתמשים רשומים יכולים לתרגם מאמרים
התחבר הרשם
CROSS-REFERENCES TO RELATED APPLICATIONS
This application is a national phase entry under 35 U.S.C. .sctn.371 of International Application No. PCT/CN2014/080938, filed on Jun. 27, 2014, which claims the priority of Chinese patent application Serial No. 201310572068.2 filed with the State
Method of assessing reperfusion after thrombolytic therapy
רק משתמשים רשומים יכולים לתרגם מאמרים
התחבר הרשם
FIELD OF THE INVENTION
The present invention relates to methods of determining if reperfusion has occurred after thrombolytic therapy during a myocardial infarction.
BACKGROUND OF THE INVENTION
Early and sustained coronary artery patency after thrombolytic therapy has been implicated as one of the
Method of assessing reperfusion after thrombolytic therapy
רק משתמשים רשומים יכולים לתרגם מאמרים
התחבר הרשם
FIELD OF THE INVENTION
The present invention relates to methods of determining if reperfusion has occurred after thrombolytic therapy during a myocardial infarction.
BACKGROUND OF THE INVENTION
Early and sustained coronary artery patency after thrombolytic therapy has been implicated as one of the
Method for the determination of creative phosphokinase enzyme
רק משתמשים רשומים יכולים לתרגם מאמרים
התחבר הרשם
BACKGROUND OF THE INVENTION
This invention relates to the detection and quantification of serum enzymes in living organisms. The term, serum enzyme, as used herein is meant to include those enzymes occurring normally in the serum, but whose concentration will depend upon or be affected by some
המאגר השלם ביותר של צמחי מרפא המגובה על ידי המדע
- עובד ב 55 שפות
- מרפא צמחי מרפא מגובה על ידי מדע
- זיהוי עשבי תיבול על ידי דימוי
- מפת GPS אינטראקטיבית - תייגו עשבי תיבול במיקום (בקרוב)
- קרא פרסומים מדעיים הקשורים לחיפוש שלך
- חפש עשבי מרפא על פי השפעותיהם
- ארגן את תחומי העניין שלך והתעדכן במחקר החדשות, הניסויים הקליניים והפטנטים
הקלד סימפטום או מחלה וקרא על צמחי מרפא שעשויים לעזור, הקלד עשב וראה מחלות ותסמינים שהוא משמש נגד.
* כל המידע מבוסס על מחקר מדעי שפורסם
